Top Story

Eight updates for National Sickle Cell Awareness Month

September 13, 2019
In the Journals

Greater cardiorespiratory fitness may reduce risk for venous thromboembolism

September 4, 2019
Higher estimated cardiorespiratory fitness levels appeared associated with a lower risk for venous thromboembolism, according to results of a population-based cohort…
FDA News

FDA grants orphan drug designation to SIG-001 for hemophilia A

August 28, 2019
The FDA has granted orphan drug designation to SIG-001, an investigational therapy under evaluation for
In the Journals

Cancer survivors at higher medium-, long-term risk for cardiovascular disease

August 23, 2019
Survivors of most types of cancers demonstrated increased medium- to long-term risk for at least one cardiovascular disease compared with the general population…
More Headlines »

New Trends in Early Recognition of CDI and CMV in HSCT:
A Care Team Forum

This activity is supported by an educational grant from Merck & Co., Inc.

Hematopoietic stem cell transplantation (HSCT) has revolutionized the treatment of many blood disorders and has seen…
More »
Meeting News Coverage

VIDEO: Direct oral anticoagulants show promise for reducing stroke, bleeding risk in patients with cancer

January 6, 2017
More »
Resource Centers

Innovations in Sickle Cell Disease: How the Latest Advances May Impact Clinical Decision-making

This activity is supported by an educational grant from Global Blood Therapeutics.

Sickle cell disease (SCD) is an inherited molecular condition whose clinical severity has extreme phenotypic…
More »